[
    {
        "molecule_name": "BMY7378",
        "protein_target_name": "α1D adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KB",
        "value": "2.95",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "prazosin (PZS)",
        "protein_target_name": "α1A adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.46",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "prazosin (PZS)",
        "protein_target_name": "α1A adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "56.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "prazosin (PZS)",
        "protein_target_name": "α1B-adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.34",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1A adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.46",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1A adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "56.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1B adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.34",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT62",
        "protein_target_name": "α1A and α1B adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "261",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT65",
        "protein_target_name": "α1A and α1B adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "67",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT66",
        "protein_target_name": "α1A and α1B adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "43",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT67",
        "protein_target_name": "α1A and α1B adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "81",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT68",
        "protein_target_name": "α1A and α1B adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "38",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT65",
        "protein_target_name": "α2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.5",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT66",
        "protein_target_name": "α2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "0.8",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT67",
        "protein_target_name": "α2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "0.5",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT68",
        "protein_target_name": "α2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "0.6",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT2",
        "protein_target_name": "5-HT1A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.24 x 10-9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT3",
        "protein_target_name": "5-HT1A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.13 x 10-9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT4",
        "protein_target_name": "5-HT1A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "9.88 x 10-10",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT5",
        "protein_target_name": "5-HT1A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "2.54 x 10-9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT62",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "147",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT65",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "18",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT66",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT67",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "18",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT68",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "9",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT2",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "4.74 x 10-8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT3",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "4.52 x 10-8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT4",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "4.42 x 10-8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT5",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "2.48 x 10-7",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT62",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "6.41",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT65",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "2.93",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT66",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.72",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT67",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.89",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    },
    {
        "molecule_name": "LDT68",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.47",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The Ki obtained values were summarized in the following Tables 3 to 5 below, including LDT2 with Ki = 1.57 x 10-8 M, LDT3 with Ki = 4.63 x 10-9 M, LDT4 with Ki = 8.81 x 10-9 M, and LDT5 with Ki = 3.67 x 10-9 M.\n6. Table 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, including LDT62 with Ki = 261 nM, LDT65 with Ki = 67 nM, LDT66 with Ki = 43 nM, LDT67 with Ki = 81 nM, and LDT68 with Ki = 38 nM.\n7. LDT66, LDT68 and LDT69 derivatives (Ki equal to 43, 38 and 33 nM, respectively) showed affinity six to eight times higher (P &lt;0.01) than LDT62 (Ki = 261 nM) (Table 5).\n8. Table 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, including LDT65 with Ki = 1.5 µM, LDT66 with Ki = 0.8 µM, LDT67 with Ki = 0.5 µM, and LDT68 with Ki = 0.6 µM.\n9. Table 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, including LDT2 with Ki = 1.24 x 10-9 M, LDT3 with Ki = 1.13 x 10-9 M, LDT4 with Ki = 9.88 x 10-10 M, and LDT5 with Ki = 2.54 x 10-9 M.\n10. Table 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, including LDT62 with Ki = 147 nM, LDT65 with Ki = 18 nM, LDT66 with Ki = 5 nM, LDT67 with Ki = 18 nM, and LDT68 with Ki = 9 nM.\n11. Table 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, including LDT2 with Ki = 4.74 x 10-8 M, LDT3 with Ki = 4.52 x 10-8 M, LDT4 with Ki = 4.42 x 10-8 M, and LDT5 with Ki = 2.48 x 10-7 M.\n12. Table 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, including LDT62 with Ki = 6.41 nM, LDT65 with Ki = 2.93 nM, LDT66 with Ki = 1.72 nM, LDT67 with Ki = 1.89 nM, and LDT68 with Ki = 1.47 nM."
    }
]